Key challenges in accelerated cell and gene therapy pathways

From preclinical risk assessments to Biologics License Application review, this infographic explores the key regulatory challenges at each critical checkpoint in the accelerated pathway for cell and gene therapies.

This infographic is part of the RegMedNet Spotlight on cell and gene therapy regulation, in association with Sartorius.

Visit the feature

RMN Q4 Sartorius Spotlight_FINAL

Illustrated by Tobias Dumbraveanu (Taylor & Francis Group, London, UK).